Search Results - "Baudoux, É."

Refine Results
  1. 1

    Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases by Grégoire, C., Lechanteur, C., Briquet, A., Baudoux, É., Baron, F., Louis, E., Beguin, Y.

    Published in Alimentary pharmacology & therapeutics (01-01-2017)
    “…Summary Background Inflammatory bowel diseases (IBD) are chronic relapsing diseases in which pro‐inflammatory immune cells and cytokines induce intestinal…”
    Get full text
    Journal Article Web Resource
  2. 2

    Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy by Baudoux, Thomas E R, Pozdzik, Agnieszka A, Arlt, Volker M, De Prez, Eric G, Antoine, Marie-Hélène, Quellard, Nathalie, Goujon, Jean-Michel, Nortier, Joëlle L

    Published in Kidney international (01-11-2012)
    “…Experimental aristolochic acid nephropathy is characterized by early tubulointerstitial injury followed by fibrosis, reproducing chronic lesions seen in…”
    Get more information
    Journal Article
  3. 3

    Influence of obstetric factors on characteristics of umbilical cord blood transplants by de Jamblinne, Y, Baudoux, E, Delo, C, Coppieters, Y

    “…There is a correlation between the success of the cord blood transplant and the numbers of HSC found in the unit of cord blood donation. The purpose of this…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Cleanrooms and tissue banking how happy I could be with either GMP or GTP? by Klykens, J., Pirnay, J.-P., Verbeken, G., Giet, O., Baudoux, E., Jashari, R., Vanderkelen, A., Ectors, N.

    Published in Cell and tissue banking (01-12-2013)
    “…The regulatory framework of tissue banking introduces a number of requirements for monitoring cleanrooms for processing tissue or cell grafts. Although a…”
    Get full text
    Journal Article Web Resource
  6. 6

    Quality controls on cord blood unit contiguous segments: Recommendation of the SFGM-TC by De Vos, J., Birebent, B., Faucher, C., Giet, O., Hicheri, Y., Lemarie, C., Baudoux, E., Boulanger, F., Garnier, F., Larghero, J., Pouthier, F., Thibert, J.-B., Yakoub-Agha, I.

    Published in Pathologie biologie (Paris) (01-08-2014)
    “…In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell…”
    Get full text
    Journal Article Conference Proceeding
  7. 7
  8. 8
  9. 9

    Conservation and destruction of autologous and allogeneic cryopreserved cellular products: recommendations from the SFGM-TC by Calmels, B, Boulanger, F, Baudoux, E, Decot, V, Fawaz, A, Giraud, C, Hivert, B, Garderet, L, Milpied, N, Yakoub-Agha, I

    Published in Pathologie biologie (Paris) (01-08-2014)
    “…Thousands of autologous and at less extent allogeneic hematopoietic stem cells (HSC) bags are cryopreserved in France. The majority of autologous HSC grafts…”
    Get full text
    Journal Article
  10. 10

    Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation by Salmon, J.-P., Michaux, S., Hermanne, J.-P., Baudoux, E., Gérard, C., Sontag-Thull, D., Fillet, G., Beguin, Y.

    Published in Transfusion (Philadelphia, Pa.) (01-08-1999)
    “…BACKGROUND: Bone marrow transplantation with minor ABO incompatibility may be followed by moderate delayed hemolysis of the recipient's red cells by…”
    Get full text
    Journal Article Web Resource
  11. 11

    Correlation between P450 CYP1A1 inducibility, Mspi genotype and lung cancer incidence by Jacquet, M., Lambert, V., Baudoux, E., Muller, M., Kremers, P., Gielen, J.

    Published in European journal of cancer (1990) (01-09-1996)
    “…The aim of this study was to verify a possible correlation between CYP1A1 induction, MspI genotype and lung cancer incidence. A case—control study was…”
    Get full text
    Journal Article
  12. 12

    Modalités de conservation et de destruction des produits cellulaires cryopréservés : recommandations de la SFGM-TC by Calmels, B., Boulanger, F., Baudoux, E., Decot, V., Fawaz, A., Giraud, C., Hivert, B., Garderet, L., Milpied, N., Yakoub-Agha, I.

    Published in Pathologie biologie (Paris) (01-08-2014)
    “…Des milliers de poches de cellules souches hématopoïétiques (CSH) autologues et à moindre degré allogéniques sont conservées en France. La majorité des poches…”
    Get full text
    Journal Article Conference Proceeding
  13. 13
  14. 14

    Autologous blood donation plus epoetin alfa in nonanemic orthopedic surgery patients by Baudoux, E

    Published in Seminars in hematology (01-04-1996)
    “…Intravenous (i.v.) administration of epoetin alfa facilitates the collection of autologous blood (AB) prior to elective orthopedic surgery. However, the…”
    Get more information
    Journal Article
  15. 15

    Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF by Fraipont, V., Sautois, B., Baudoux, E., Pereira, M., Fassotte, M.-F., Hermanne, J.-P., Jérusalem, G., Longrée, L., Schaaf-Lafontaine, N., Fillet, G., Beguin, Y.

    Published in Transfusion (Philadelphia, Pa.) (01-03-2000)
    “…BACKGROUND: Mobilization with chemotherapy and G–CSF may result in poor peripheral blood HPC collection, yielding <2 × 106 CD34+ cells per kg or <10 × 104…”
    Get full text
    Journal Article Web Resource
  16. 16
  17. 17

    Cellular immunotherapy at the University Hospital of Liege : advances, challenges and prospects by Grégoire, C, Servais, S, Willems, E, Baudoux, E, Lechanteur, C, Briquet, A, Bettonville, V, Detry, O, Erpicum, P, Jouret, F, Louis, E, Baron, F, Beguin, Y

    Published in Revue médicale de Liège (01-04-2022)
    “…Cellular immunotherapy consists in using the cells of the immune system as a therapeutic weapon. In this constantly evolving field, the therapeutic strategies…”
    Get more information
    Journal Article
  18. 18

    Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells by Beguin, Y., Baudoux, E., Sautois, B., Fraipont, V., Schaaf-Lafontaine, N., Pereira, M., Paulus, J.M., Sondag, D., Fillet, G.

    Published in Transfusion (Philadelphia, Pa.) (01-02-1998)
    “…BACKGROUND: A study of CD34+ cell selection and transplantation was carried out with particular emphasis on characteristics of short‐ and long‐term…”
    Get full text
    Journal Article Web Resource
  19. 19
  20. 20

    Hemovigilance: Clinical Tolerance of Solvent-Detergent Treated Plasma by Baudoux, E., Margraff, U., Coenen, A., Jacobs, X., Strivay, M., Lungu, C., Sondag-Thull, D.

    Published in Vox sanguinis (01-01-1998)
    “…Objective: This study was conducted to assess retrospectively the clinical tolerance of SD treated plasma and to compare it to other labile blood products (red…”
    Get full text
    Journal Article Web Resource